HAS' fourth-quarter top line reflects dismal contributions from The Wizards of the Coast, and Digital Gaming and Consumer Products segments.

RARE reports mixed fourth-quarter results, as earnings miss estimates while revenues beat the same. Product sales increase year over year.

ZBRA's fourth-quarter 2024 revenues surge 32.2% year over year, driven by strength in the Asset Intelligence & Tracking and Enterprise Visibility &...

AVNT's fourth-quarter organic sales rise 5% year over year aided by growth in all geographic regions.

CNP's Q4 revenues of $2.26 billion miss the Zacks Consensus Estimate by 0.9%. The top line, however, improves 3.7% from the year-ago reported figure.

ALKS reports better-than-expected fourth-quarter 2024 results. Net sales of proprietary products increase year over year. Shares rise.

FLS' fourth-quarter 2024 revenues increase 1.3% year over year, driven by the impressive performance of its Flowserve Flow Control Division unit.

Robust segmental performances benefit RSG's top line in the fourth quarter of 2024.

Incyte reports mixed fourth-quarter 2024 results as earnings miss estimates while revenues beat the same. Jakafi and Opzelura drive year-over-year...

MRNA's earnings and revenues surpass estimates in the fourth quarter of 2024. The company reiterates 2025 total revenue guidance.